- Home
- OKYO vs ISPR Comparison
OKYO vs ISPR Comparison
Compare OKYO & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OKYO | ISPR |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.7M | 103.9M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | OKYO | ISPR |
|---|---|---|
| Price | $1.54 | $1.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $6.33 | ★ $7.50 |
| AVG Volume (30 Days) | 53.7K | ★ 136.9K |
| Earning Date | 07-18-2025 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $127,494,304.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.42 | $1.19 |
| 52 Week High | $3.35 | $3.87 |
Technical Indicators
Market Signals| Indicator | OKYO | ISPR |
|---|---|---|
| Relative Strength Index (RSI) | 41.13 | 45.16 |
| Support Level | $1.48 | $1.56 |
| Resistance Level | $1.73 | $1.98 |
| Average True Range (ATR) | 0.10 | 0.16 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 32.35 | 20.00 |
Price Performance
Historical ComparisonAbout OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.